Cargando…

Zinc transporter HKE4 as a new target in antihormone resistance of breast cancer

Detalles Bibliográficos
Autores principales:	Taylor, KM, Jordan, N, Hiscox, S, Gee, JM, Nicholson, RI
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3300745/ http://dx.doi.org/10.1186/bcr1926

Ejemplares similares

Overexpression of CD44 in acquired tamoxifen-resistant breast cancer cells augments their migratory response to heregulin beta 1
por: Hiscox, S, et al.
Publicado: (2008)

Buthionine sulfoximine sensitizes antihormone-resistant human breast cancer cells to estrogen-induced apoptosis
por: Lewis-Wambi, Joan S, et al.
Publicado: (2008)

Recruitment of insulin receptor substrate-1 by erbB3 impacts on IGF-IR signalling in oestrogen receptor-positive breast cancer cells
por: Knowlden, JM, et al.
Publicado: (2010)

Correction to: Buthionine sulfoximine sensitizes antihormone-resistant human breast cancer cells to estrogen-induced apoptosis
por: Lewis-Wambi, Joan S., et al.
Publicado: (2018)

DOES THE GONADOTROPIC HORMONE INDUCE ANTIBODIES OR ANTIHORMONES?
por: Sulman, Felix
Publicado: (1937)

Fulvestrant-induced expression of erbB3 and erbB4 sensitizes ER-positive breast cancer cells to heregulins
por: Hutcheson, IR, et al.
Publicado: (2010)

Antihormonal treatment associated musculoskeletal pain in women with breast cancer in the adjuvant setting
por: Seber, Selcuk, et al.
Publicado: (2016)

Predictors of adherence and the role of primary non-adherence in antihormonal treatment of breast cancer
por: Dragvoll, Ida, et al.
Publicado: (2022)

By looking back we can see the way forward: enhancing the gains achieved with antihormone therapy
por: Jordan, V Craig, et al.
Publicado: (2008)

Characterization of Formononetin Sulfonation in SULT1A3 Overexpressing HKE293 Cells: Involvement of Multidrug Resistance-Associated Protein 4 in Excretion of Sulfate
por: Liu, Fanye, et al.
Publicado: (2021)

Proceedings: Prediction of response to antihormone treatment using an in vitro test for dependence of hormones.
por: Salih, H., et al.
Publicado: (1974)

Anti-oestrogen therapy switches off tumour suppressors and proapoptotic genes in breast cancer and reveals a new therapeutic opportunity
por: Stone, A, et al.
Publicado: (2008)

Microarray studies reveal novel genes associated with endocrine resistance in breast cancer
por: Burmi, RS, et al.
Publicado: (2006)

THE CULTURE OF WHOLE ORGANS : III. THE PROBLEM OF ANTIHORMONES STUDIED ON ISOLATED LIVING THYROID GLANDS
por: Okkels, Harald
Publicado: (1937)

Genetic resistance to GAHV-2 induced lymphoma in the chicken model
por: Miller, MM, et al.
Publicado: (2009)

The importance of targeting signalling mechanisms of the SLC39A family of zinc transporters to inhibit endocrine resistant breast cancer
por: Jones, Samuel, et al.
Publicado: (2022)

Comparing the Efficacy and Safety of Denosumab with Bisphosphonates in Increasing Bone Mineral Density in Patients with Prostate Cancer and Breast Cancer on Antihormonal Treatment
por: Razaq, Abdul, et al.
Publicado: (2019)

Antihormonal agents as a strategy to improve the effect of chemo-radiation in cervical cancer: in vitro and in vivo study
por: Segovia-Mendoza, Mariana, et al.
Publicado: (2015)

Activated zinc transporter ZIP7 as an indicator of anti-hormone resistance in breast cancer
por: Ziliotto, Silvia, et al.
Publicado: (2019)

Coordination characterization of zinc metalloproteins
por: Yao, Sen, et al.
Publicado: (2014)

Could side population cells be an indicator of progression to hormone nonresponsive breast cancer
por: Britton, KM, et al.
Publicado: (2010)

Exploiting monocarboxylate transporters as new molecular targets for colorectal carcinoma therapy
por: Amorim, Ricardo, et al.
Publicado: (2013)

Emergency general surgery, malnutrition and outcomes in critical illness
por: Havens, JM, et al.
Publicado: (2015)

Engineering SIV-resistant macaque hematopoietic stem cells and CD4+ T cells with CCR5-specific zinc-finger nucleases
por: Bonello, G, et al.
Publicado: (2012)

Plasma zinc concentration and children's infectious diseases
por: Negruț, Nicoleta, et al.
Publicado: (2013)

Plasma zinc level during acute gastroenteritis
por: Negruț, Nicoleta
Publicado: (2014)

Antihormone treatment differentially regulates PSA secretion, PSMA expression and (68)Ga–PSMA uptake in LNCaP cells
por: Mathy, C. S., et al.
Publicado: (2021)

FOXM1 is a transcriptional target of ERα and has a critical role in breast cancer endocrine sensitivity and resistance
por: Millour, J, et al.
Publicado: (2010)

Oestrogen and growth factor cross-talk and endocrine insensitivity and acquired resistance in breast cancer
por: Nicholson, RI, et al.
Publicado: (2000)

Selenium and zinc plasmatic levels in intensive care patients
por: Kazda, A, et al.
Publicado: (2004)

Bevacizumab resistance in breast cancer: are neuropilins the key?
por: Staton, CA, et al.
Publicado: (2008)

Molecular prediction of tamoxifen resistance in breast cancer
por: Kok, M, et al.
Publicado: (2005)

The effects of creatine monohydrate supplementation on creatine transporter activity and creatine metabolism in resistance trained males
por: Andre, Tom, et al.
Publicado: (2015)

Food choice and phytoestrogen consumption in women previously treated for postmenopausal breast cancer
por: Parry, BM, et al.
Publicado: (2008)

Prognostic value of serum zinc levels in critically ill patients
por: Cander, B, et al.
Publicado: (2010)

The effect of zinc therapy on electrolyte balance in children with acute diarrhea
por: Negruț, Nicoleta
Publicado: (2013)

Evaluating the effect of chromosomal context on zinc finger nuclease efficiency
por: Bahr, Scott, et al.
Publicado: (2013)

C35 overexpression defines subsets of human breast cancer and its immunoreceptor tyrosine-based activation motif represents a novel treatment target
por: Katz, E, et al.
Publicado: (2008)

Thioredoxin and related redox systems as targets in breast cancer
por: Woolston, CM, et al.
Publicado: (2010)

Profiling metabolic changes in breast cancer with targeted proteomics
por: Bernhardt, Stephan, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_cne1hvhd157mobjm017ka0c8jf